Drug Information

Drug General Information
Drug ID
D01EIS
Former ID
DNC006815
Drug Name
1-(1,2-diphenylethyl)piperazine
Drug Type
Small molecular drug
Indication Discovery agent Investigative [528224]
Structure
Download
2D MOL

3D MOL
Formula
C18H22N2
Canonical SMILES
C1CN(CCN1)C(CC2=CC=CC=C2)C3=CC=CC=C3
InChI
1S/C18H22N2/c1-3-7-16(8-4-1)15-18(17-9-5-2-6-10-17)20-13-11-19-12-14-20/h1-10,18-19H,11-15H2
InChIKey
NIBIYLDNVMUKNB-UHFFFAOYSA-N
PubChem Compound ID
12263801
Target and Pathway
Target(s) Sodium-dependent noradrenaline transporter Target Info Inhibitor [528224]
Sodium-dependent serotonin transporter Target Info Inhibitor [528224]
KEGG Pathway Serotonergic synapse
NetPath Pathway TCR Signaling Pathway
PANTHER Pathway Adrenaline and noradrenaline biosynthesisP04373:5HT1 type receptor mediated signaling pathway
5HT2 type receptor mediated signaling pathway
5HT3 type receptor mediated signaling pathway
5HT4 type receptor mediated signaling pathway
Reactome Na+/Cl- dependent neurotransmitter transporters
WikiPathways Monoamine Transport
NRF2 pathway
Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compoundsWP727:Monoamine Transport
SIDS Susceptibility Pathways
Synaptic Vesicle Pathway
Serotonin Transporter Activity
References
Ref 528224Bioorg Med Chem Lett. 2006 Aug 15;16(16):4345-8. Epub 2006 Jun 5.N-(1,2-diphenylethyl)piperazines: a new class of dual serotonin/noradrenaline reuptake inhibitor.
Ref 528224Bioorg Med Chem Lett. 2006 Aug 15;16(16):4345-8. Epub 2006 Jun 5.N-(1,2-diphenylethyl)piperazines: a new class of dual serotonin/noradrenaline reuptake inhibitor.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.